Danaher Corporation (DHR) on Decifer

Why it ranks here

• Sales are growing about 8% a year, faster than 33 in 100 companies we measure.
• It keeps about 21 cents of every sales dollar as cash, safer than 84 in 100 companies we measure.
• It earns about 6% a year on the money put into the business, better than 33 in 100 companies we measure.
• It costs about 41 times its yearly profit; the middle of its industry is 38. Cheaper than 39 in 100 companies we measure, against their own industries.

The current read

The evidence on DHR lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Genomic Medicine & Precision Diagnostics: The collapsing cost of DNA/RNA sequencing and validation of genomic classifiers is moving clinical practice toward routine molecular diagnostics and companion testing.

Read the full DHR research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.